Definitive Proton Beam Therapy for Second Primary Non-small Cell Lung Cancer After Pneumonectomy.
Masatoshi Nakamura, Kayoko Ohnishi, Toshiyuki Okumura, Den Fujioka, Keiichiro Baba, Motohiro Murakami, Masashi Mizumoto, Ikuo Sekine, Masaharu Inagaki, Yukio Sato, Hideyuki Sakurai
Abstract
Open AccessPurpose: To investigate the outcome of definitive proton beam therapy (PBT) for second primary non-small cell lung cancer after pneumonectomy. Patients and Methods: Between January 2006 and December 2019, 4 patients with second primary lung cancer occurring in the contralateral lung after pneumonectomy were selected from our database of patients who underwent PBT. All patients were men with a median age of 69 (range, 61-79) years at the time of PBT. The median time from pneumonectomy to PBT initiation was 104.5 (range, 92-117) months. All patients had a histology of squamous cell carcinoma and were inoperable due to poor respiratory function. Results: The median survival time was 46.6 (range, 11.7-118.4) months; 3 patients died of their primary disease and one of bacterial pneumonia. The first relapses were local recurrence inside the irradiated field (n = 1) and outside the irradiated field (n = 2) and regional (n = 1). The median time to relapse was 21.5 (range, 6.6-48.1) months. Regarding adverse events, grade 2 pneumonitis occurred in 2 patients, but steroid administration was not required; no grade ≥3 pneumonitis was observed. Conclusion: Definitive PBT for new lesions in the residual lung after pneumonectomy was successful without serious adverse events, although the number of cases was small.